1308299-21-9

Basic information

• Product Name: (S)-3-((3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methylamino)-4-methoxycyclobut-3-ene-1,2-dione
• Synonyms: (S)-3-((3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methylamino)-4-methoxycyclobut-3-ene-1,2-dione
• CAS NO: 1308299-21-9
• Molecular Weight: 405.383
• Mol File: 1308299-21-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (S)-3-((3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methylamino)-4-methoxycyclobut-3-ene-1,2-dione(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-3-((3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methylamino)-4-methoxycyclobut-3-ene-1,2-dione(1308299-21-9)
• EPA Substance Registry System: (S)-3-((3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methylamino)-4-methoxycyclobut-3-ene-1,2-dione(1308299-21-9)

Safety Data

• Hazardous Substances Data: 1308299-21-9(Hazardous Substances Data)

Upstream product

• 168828-84-0 (R)-5-azidomethyl-3-(3-fluoro-4-(morpholin-4-yl)phenyl)oxazolidin-2-one 
• 5222-73-1 3,4-dimethoxy-3-cyclobutene-1,2-dione 
• 168828-90-8 (S)-N-[[3-[3-fluoro-4-[4-morpholinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]amine 

Downstream Products

• 1308299-25-3 (S)-3-((3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methylamino)-4-morpholinocyclobut-3-ene-1,2-dione 
• 1308299-22-0 (S)-3-((3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methylamino)-4-(methylamino)cyclobut-3-ene-1,2-dione 
• 1308299-23-1 (S)-3-(ethylamino)-4-((3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methylamino)cyclobut-3-ene-1,2-dione 
• 1308299-24-2 (S)-3-((3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methylamino)-4-(2-hydroxyethylamino)cyclobut-3-ene-1,2-dione 

Relevant articles and documents

The effect of systematic structural modifications on the antibacterial activity of novel oxazolidinones

A novel series of tetraethylene glycol (TEG) triazolyl and squaramide containing oxazolidinones were synthesized and tested for their antibacterial activity against a selected panel of Gram-positive and Gram-negative bacteria. The 4-TEG-triazolyl derivatives were prepared by 'click reaction'. The introduction of the TEG and squaramide groups did not favor antibacterial activity. The three nucleoside-containing oxazolidinones were also prepared by 'click' methodology resulted in weak antibacterial activity.